HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Schering’s Rocky Succession: Former Mining Exec To Head CEO Search

This article was originally published in The Tan Sheet

Executive Summary

Schering-Plough interim Chairman Richard Osborne is likely to be wary of mergers as a turnaround strategy for the company

You may also be interested in...



Schering Turnaround Needs 5 Years, CEO Hassan Says; First Step: Buy Time

Schering-Plough CEO Fred Hassan's turnaround plan for the company relies on a careful balance of near-term markers coupled with a message of patience to buy time to execute a five- to seven-year plan

SEC inquiry

Schering receives "Wells Notice" March 11 notifying firm of SEC staff decision to recommend the commission bring a civil action against firm and CEO Richard Kogan regarding Oct. 3 earnings warning, which was preceded by closed-door investor meetings (1"The Tan Sheet" Nov. 18, 2003, p. 13). Schering can now file legal brief...

Schering NDAs Not Subject To Extra Scrutiny Under FDA Consent Decree

Schering-Plough's pending supplemental NDAs to switch Claritin (loratadine) OTC appear to be unaffected by the company's GMP consent decree with FDA

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS130942

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel